Seroepidemiology of Hepatitis B in the Democratic Republic of the Congo.


Journal

The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507

Informations de publication

Date de publication:
07 2019
Historique:
pubmed: 11 5 2019
medline: 22 1 2020
entrez: 11 5 2019
Statut: ppublish

Résumé

Hepatitis B virus (HBV) is endemic throughout Africa, but its prevalence in the Democratic Republic of the Congo (DRC) is incompletely understood. We used dried blood spot (DBS) samples from the 2013 to 2014 Demographic and Health Survey in the DRC to measure the prevalence of HBV using the Abbott ARCHITECT HBV surface antigen (HBsAg) qualitative assay. We then attempted to sequence and genotype HBsAg-positive samples. The weighted national prevalence of HBV was 3.3% (95% CI: 1.8-4.7%), with a prevalence of 2.2% (95% CI: 0.3-4.1%) among children. Hepatitis B virus cases occurred countrywide and across age strata. Genotype E predominated (60%), and we found a unique cluster of genotype A isolates (30%). In conclusion, DBS-based HBsAg testing from a nationally representative survey found that HBV is common and widely distributed among Congolese adults and children. The distribution of cases across ages suggests ongoing transmission and underscores the need for additional interventions to prevent HBV infection.

Identifiants

pubmed: 31074406
doi: 10.4269/ajtmh.18-0883
pmc: PMC6609197
doi:

Substances chimiques

Hepatitis B Surface Antigens 0
Hepatitis B Vaccines 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

226-229

Références

BMC Infect Dis. 2017 Nov 1;17(Suppl 1):700
pubmed: 29143672
J Clin Microbiol. 2017 May;55(5):1299-1312
pubmed: 28202798
BMC Res Notes. 2017 Dec 2;10(1):665
pubmed: 29197421
PLoS One. 2016 Nov 7;11(11):e0166201
pubmed: 27820845
World J Hepatol. 2015 Oct 18;7(23):2482-91
pubmed: 26483870
World J Gastroenterol. 2014 Jun 21;20(23):7152-68
pubmed: 24966586
J Med Virol. 2009 Mar;81(3):435-40
pubmed: 19152415
Infect Agent Cancer. 2016 Sep 15;11:51
pubmed: 27651827
J Infect Dis. 2004 Jul 15;190(2):400-8
pubmed: 15216479
J Clin Virol. 2015 Oct;71:10-7
pubmed: 26370308
Clin Infect Dis. 2018 Jan 6;66(2):254-260
pubmed: 29048459
Clin Infect Dis. 2017 Mar 15;64(6):796-803
pubmed: 28200031
J Med Virol. 2018 Feb;90(2):250-254
pubmed: 28460156

Auteurs

Peyton Thompson (P)

Division of Infectious Diseases, Department of Pediatrics, University of North Carolina, Chapel Hill, North Carolina.

Jonathan B Parr (JB)

Division of Infectious Diseases, Department of Medicine, University of North Carolina, Chapel Hill, North Carolina.

Vera Holzmayer (V)

Abbott Laboratories, Abbott Park, Illinois.

Margaret Carrel (M)

Department of Geographical and Sustainability Sciences, University of Iowa, Iowa City, Iowa.

Antoinette Tshefu (A)

Kinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo.

Kashamuka Mwandagalirwa (K)

Kinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo.

Jérémie Muwonga (J)

National AIDS Control Program, Kinshasa, Democratic Republic of the Congo.

Placide O Welo (PO)

National AIDS Control Program, Kinshasa, Democratic Republic of the Congo.

Franck Fwamba (F)

National AIDS Control Program, Kinshasa, Democratic Republic of the Congo.

Mary Kuhns (M)

Abbott Laboratories, Abbott Park, Illinois.

Ravi Jhaveri (R)

Division of Infectious Diseases, Department of Pediatrics, Northwestern University, Evanston, Illinois.

Steven R Meshnick (SR)

Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina.

Gavin Cloherty (G)

Abbott Laboratories, Abbott Park, Illinois.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH